Medicine & Life Sciences
Alchemix
21%
Alkylating Agents
5%
Ataxia Telangiectasia
49%
AZD6738
5%
B-Cell Chronic Lymphocytic Leukemia
100%
Cell Count
6%
Cell Death
7%
Chromosome Aberrations
6%
Cyclin-Dependent Kinase 2
6%
Cytogenetics
8%
DNA Damage
22%
Double-Stranded DNA Breaks
6%
Heterografts
21%
Histones
7%
In Vitro Techniques
7%
Leukemia
8%
Lymphocytes
7%
Mutation
23%
Natural History
8%
Natural Killer Cells
7%
Neoplasms
12%
olaparib
13%
Pediatrics
5%
Phenotype
8%
Poly(ADP-ribose) Polymerase Inhibitors
22%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8%
Proteins
5%
Radiation Tolerance
6%
Reactive Oxygen Species
6%
Recombinational DNA Repair
11%
Sequence Deletion
6%
Survival
6%
Synthetic Lethal Mutations
12%
T-Lymphocytes
6%
Therapeutics
6%
Toll-Like Receptor 9
11%
Topoisomerase Inhibitors
6%
Ubiquitin
8%
Ubiquitin-Specific Proteases
12%
Chemistry
Antineoplastic Agent
7%
Cell Death
18%
Dose
6%
Genotoxic
10%
Haematological
12%
Histone
9%
Ibrutinib
15%
Lethal
10%
Metabolic
6%
Mutation
19%
Olaparib
15%
Phosphotransferase Inhibitor
10%
Plasma
5%
Poly(ADPribose)
11%
Proliferative
11%
Protein
7%
Reduction
7%
Refractory
11%
Resistance
7%
Time
5%
Tyrosine
5%